Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada

Nav

General Info

Geography

Canada (CAN)

Coverage type

Country

Time period covered

01/2013 - 12/2014

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Brogan AJ, Smets E, Mauskopf JA, Manuel SA, Adriaenssen I

Journal

Pharmacoeconomics

Volume

Issue

Pages

903-17

Publication year

2014

Suggested citation

Brogan AJ, Smets E, Mauskopf JA, Manuel SA, Adriaenssen I. Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada. Pharmacoeconomics. 2014; 32(9): 903-17.

PMID

24906477

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada

Nav